Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:37 AM
Ignite Modification Date:
2025-12-25 @ 2:37 AM
NCT ID:
NCT02648334
Eligibility Criteria:
Inclusion Criteria:
* Age 19 and above
* Subject with claudication or critical limb ischemia(Rutherford classification level 2\~5)
* Subject with total occlusion or stenosis ≥70%(de novo, restenosis)
* Vessel diameter 4\~6mm
* Success to guide wire pass
* Patients who don't have known hypersensitivity or allergy for dual-platelets
* Willing and able to provide informed written consent
Exclusion Criteria:
* Acute stage
* Acute thrombosis in target limb or target vessel
* Failure to guide wire pass
* Distal outflow
* Lesion with poor inflow
* Life expectancy ≤ 2 years
* Allergic to paclitaxel
* Pregnant or breast feeding woman or disagree with contraception or having children
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT02648334
Study Brief:
Protocol Section:
NCT02648334